Trubion Pharmaceuticals Inc. Reports Second-Quarter Financial Results

Trubion Pharmaceuticals Inc. (TRBN) today announced financial results for its second quarter and six months ended June 30, 2010.

Revenue for the second quarter and six months ended June 30, 2010, increased to $5.7 million and $11.2 million, respectively, compared with $4.1 million and $8.3 million, respectively, in 2009.

Total operating expenses for the second quarter and first half of 2010 were $11.3 million and $22.8 million, respectively, compared with $10.7 million and $25.9 million in 2009.

Trubion Pharmaceuticals' net loss for the second quarter and six months ended June 30, 2010, decreased to $5.7 million, or $0.28 per diluted common share, and $11.8 million, or $0.58 per diluted common share, respectively.